{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:33:08Z","timestamp":1789187588406,"version":"build-2803163510"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100007311","name":"German Childhood Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007311","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinician Scientist Program","award":["CS4RARE"],"award-info":[{"award-number":["CS4RARE"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The outcome of children with medulloblastoma (MB) and Fanconi Anemia (FA), an inherited DNA repair deficiency, has not been described systematically. Treatment is complicated by high vulnerability to treatment-associated side effects, yet structured data are lacking. This study aims to give a comprehensive overview of clinical and molecular characteristics of pediatric FA MB patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Clinical data including detailed information on the treatment and toxicities of 6 previously unreported FA MB patients were supplemented with data of 16 published cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 22 cases of children with FA and MB with clinical data available. All MBs with subgroup reporting were SHH-activated (n\u2005=\u20059), confirmed by methylation profiling in 5 patients. FA MB patients exclusively belonged to complementation groups FA-D1 (n\u2005=\u200516) or FA-N (n\u2005=\u20053). Patients were treated with postoperative chemotherapy only (50%) or radiotherapy (RT)\u2005\u00b1\u2005chemotherapy (27%). Of 23% did not receive adjuvant therapy. Excessive treatment-related toxicities were frequent. Severe hematological toxicity occurred in 91% of patients treated with alkylating chemotherapy, while non-alkylating agents and RT were less toxic. Median overall survival (OS) was 1 year (95%CI: 0.3\u20131.8). 1-year-progression-free-survival (PFS) was 26.3%\u2005\u00b1\u200510.1% and 1-year-OS was 42.1%\u2005\u00b1\u200511.3%. Adjuvant therapy prolonged survival (1y-OS\/1y-PFS 0%\/0% without adjuvant therapy vs. 53.3%\u2005\u00b1\u200512.9%\/33.3\u2005\u00b1\u200512.2% with adjuvant therapy, P\u2005=\u2005.006\/P\u2005=\u2005.086).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>MB in FA patients is strongly associated with SHH activation and FA-D1\/FA-N. Despite the dismal prognosis, adjuvant therapy may prolong survival. Non-alkylating chemotherapy and RT are feasible in selected patients with careful monitoring of toxicities and dose adjustments. Curative therapy for FA MB-SHH remains an unmet medical need.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noae111","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T21:57:08Z","timestamp":1719266228000},"page":"2125-2139","source":"Crossref","is-referenced-by-count":5,"title":["Medulloblastoma in children with Fanconi anemia: Association with FA-D1\/FA-N, SHH type and poor survival independent of treatment strategies"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0845-6881","authenticated-orcid":false,"given":"Marthe","family":"S\u00f6nksen","sequence":"first","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-8452","authenticated-orcid":false,"given":"Denise","family":"Obrecht-Sturm","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Hern\u00e1iz Driever","sequence":"additional","affiliation":[{"name":"Charit\u00e9-Universit\u00e4tsmedizin Berlin, Corporate Member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin, Department of Pediatric Oncology and Hematology , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Sauerbrey","sequence":"additional","affiliation":[{"name":"Pediatric Clinics, Helios Hospital , Erfurt ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Graf","sequence":"additional","affiliation":[{"name":"Department of Pediatric Oncology and Hematology, Saarland University , Homburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Kontny","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University , Aachen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Reimann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm , Ulm ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Langhein","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe R","family":"Kordes","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Department for Radiotherapy, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Obser","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Boschann","sequence":"additional","affiliation":[{"name":"Berlin Institute of Health at Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin , Berlin ,","place":["Germany"]},{"name":"Institute of Medical Genetics and Human Genetics, Charit\u00e9-Universit\u00e4tsmedizin Berlin, corporate member of Freie Universit\u00e4t Berlin and Humboldt-Universit\u00e4t zu Berlin , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-1121","authenticated-orcid":false,"given":"Ulrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"Research Institute Children\u2019s Cancer Center Hamburg , Hamburg ,","place":["Germany"]},{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Altendorf","sequence":"additional","affiliation":[{"name":"Research Institute Children\u2019s Cancer Center Hamburg , Hamburg ,","place":["Germany"]},{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Goschzik","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Brain Tumor Reference Center of the German Society for Neuropathology and Neuroanatomy (DGNN), University of Bonn Medical Center , Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Brain Tumor Reference Center of the German Society for Neuropathology and Neuroanatomy (DGNN), University of Bonn Medical Center , Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3302-2719","authenticated-orcid":false,"given":"Martin","family":"Mynarek","sequence":"additional","affiliation":[{"name":"Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]},{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-9571","authenticated-orcid":false,"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"issue":"1","key":"2024110422225180100_CIT0001","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-cancerbio-030617-050422","article-title":"The Fanconi anemia pathway in cancer","volume":"3","author":"Niraj","year":"2019","journal-title":"Annu Rev Cancer Biol"},{"issue":"4","key":"2024110422225180100_CIT0002","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood."},{"issue":"10","key":"2024110422225180100_CIT0003","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3390\/genes12101520","article-title":"Fanconi anaemia, childhood cancer and the BRCA genes","volume":"12","author":"Woodward","year":"2021","journal-title":"Genes (Basel)"},{"key":"2024110422225180100_CIT0004","doi-asserted-by":"crossref","first-page":"100589","DOI":"10.1016\/j.blre.2019.100589","article-title":"Genotype-phenotype associations in Fanconi anemia: A literature review","volume":"37","author":"Fiesco-Roa","year":"2019","journal-title":"Blood Rev."},{"issue":"11","key":"2024110422225180100_CIT0005","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng1458","article-title":"X-linked inheritance of Fanconi anemia complementation group B","volume":"36","author":"Meetei","year":"2004","journal-title":"Nat Genet."},{"key":"2024110422225180100_CIT0006","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1038\/ncomms9829","article-title":"A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51","volume":"6","author":"Ameziane","year":"2015","journal-title":"Nat Commun."},{"issue":"1","key":"2024110422225180100_CIT0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.21.01495","article-title":"Cancer in children with Fanconi anemia and ataxia-telangiectasia-a Nationwide Register-Based Cohort Study in Germany","volume":"40","author":"Dutzmann","year":"2022","journal-title":"J Clin Oncol."},{"issue":"12","key":"2024110422225180100_CIT0008","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00439-022-02462-9","article-title":"Fanconi anemia: Current insights regarding epidemiology, cancer, and DNA repair","volume":"141","author":"Peake","year":"2022","journal-title":"Hum Genet."},{"issue":"1-2","key":"2024110422225180100_CIT0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mrfmmm.2009.01.013","article-title":"Fanconi anemia and its diagnosis","volume":"668","author":"Auerbach","year":"2009","journal-title":"Mutat Res."},{"key":"2024110422225180100_CIT0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cancergen.2021.10.001","article-title":"Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2)","volume":"258-259","author":"McReynolds","year":"2021","journal-title":"Cancer Genet"},{"issue":"1","key":"2024110422225180100_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.2006.043257","article-title":"Clinical and molecular features associated with biallelic mutations in FANCD1\/BRCA2","volume":"44","author":"Alter","year":"2007","journal-title":"J Med Genet."},{"issue":"2","key":"2024110422225180100_CIT0012","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat Genet."},{"key":"2024110422225180100_CIT0013","doi-asserted-by":"crossref","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","article-title":"Alex\u2019s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol."},{"issue":"8","key":"2024110422225180100_CIT0014","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"18","key":"2024110422225180100_CIT0015","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.19.03057","article-title":"Nonmetastatic medulloblastoma of early childhood: Results from the prospective clinical trial HIT-2000 and an extended validation cohort","volume":"38","author":"Mynarek","year":"2020","journal-title":"J Clin Oncol."},{"issue":"7","key":"2024110422225180100_CIT0016","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1200\/JCO.20.01372","article-title":"Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: Results of an international phase III trial (SJMB03)","volume":"39","author":"Gajjar","year":"2021","journal-title":"J Clin Oncol."},{"issue":"1","key":"2024110422225180100_CIT0017","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00043426-200401000-00016","article-title":"Medulloblastoma as a first presentation of fanconi anemia","volume":"26","author":"Tischkowitz","year":"2004","journal-title":"J Pediatr Hematol Oncol."},{"issue":"5","key":"2024110422225180100_CIT0018","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1651-2227.2001.tb00803.x","article-title":"Microcephalus, medulloblastoma and excessive toxicity from chemotherapy: An unusual presentation of Fanconi anaemia","volume":"90","author":"Ruud","year":"2001","journal-title":"Acta Paediatr."},{"issue":"2","key":"2024110422225180100_CIT0019","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/pbc.21966","article-title":"Wilms tumor, AML and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia","volume":"53","author":"Sari","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"2024110422225180100_CIT0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40364-015-0038-z","article-title":"Characterization of medulloblastoma in Fanconi anemia: A novel mutation in the BRCA2 gene and SHH molecular subgroup","volume":"3","author":"Miele","year":"2015","journal-title":"Biomark Res"},{"issue":"4","key":"2024110422225180100_CIT0021","first-page":"367","article-title":"Fanconi\u2019s anemia, medulloblastoma, Wilms\u2019 tumor, horseshoe kidney, and gonadal dysgenesis","volume":"109","author":"de Chadar\u00e9vian","year":"1985","journal-title":"Arch Pathol Lab Med."},{"issue":"2","key":"2024110422225180100_CIT0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/jmedgenet-2013-101642","article-title":"Fanconi anaemia, BRCA2 mutations and childhood cancer: A developmental perspective from clinical and epidemiological observations with implications for genetic counselling","volume":"51","author":"Meyer","year":"2014","journal-title":"J Med Genet."},{"issue":"7697","key":"2024110422225180100_CIT0023","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature."},{"issue":"6","key":"2024110422225180100_CIT0024","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral heterogeneity within medulloblastoma subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"2024110422225180100_CIT0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/jmg.2004.022673","article-title":"Biallelic BRCA2 mutations are associated with multiple malignancies in childhood including familial Wilms tumour","volume":"42","author":"Reid","year":"2005","journal-title":"J Med Genet."},{"issue":"6","key":"2024110422225180100_CIT0026","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archpedi.1994.02170060115027","article-title":"Brain tumors in patients with Fanconi\u2019s anemia","volume":"148","author":"Alter","year":"1994","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"20","key":"2024110422225180100_CIT0027","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/jnci\/djg072","article-title":"Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia","volume":"95","author":"Offit","year":"2003","journal-title":"J Natl Cancer Inst."},{"issue":"7","key":"2024110422225180100_CIT0028","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1182\/blood-2003-06-1970","article-title":"Association of biallelic BRCA2\/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood","volume":"103","author":"Hirsch","year":"2004","journal-title":"Blood."},{"issue":"6","key":"2024110422225180100_CIT0029","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/pbc.22139","article-title":"Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor","volume":"53","author":"Dewire","year":"2009","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2024110422225180100_CIT0030","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/pbc.23168","article-title":"The clinical phenotype of children with Fanconi anemia caused by biallelic FANCD1\/BRCA2 mutations","volume":"58","author":"Myers","year":"2012","journal-title":"Pediatr Blood Cancer."},{"issue":"5","key":"2024110422225180100_CIT0031","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/08880018.2013.788593","article-title":"Sequential development of Wilms tumor and medulloblastoma in a child: An unusual presentation of fanconi anemia","volume":"30","author":"Rizk","year":"2013","journal-title":"Pediatr Hematol Oncol."},{"issue":"3","key":"2024110422225180100_CIT0032","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejmg.2015.11.013","article-title":"Fanconi anemia with biallelic FANCD1\/BRCA2 mutations - case report of a family with three affected children","volume":"59","author":"Svojgr","year":"2016","journal-title":"Eur J Med Genet."},{"issue":"3","key":"2024110422225180100_CIT0033","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-020-00165-6","article-title":"Novel intronic variant in PALB2 gene and effective prevention of Fanconi anemia in family","volume":"19","author":"Viakhireva","year":"2020","journal-title":"Fam Cancer."},{"issue":"8","key":"2024110422225180100_CIT0034","doi-asserted-by":"crossref","first-page":"104260","DOI":"10.1016\/j.ejmg.2021.104260","article-title":"A homozygous nonsense mutation early in exon 5 of BRCA2 is associated with very severe Fanconi anemia","volume":"64","author":"Radulovic","year":"2021","journal-title":"Eur J Med Genet."},{"issue":"7","key":"2024110422225180100_CIT0035","doi-asserted-by":"crossref","first-page":"e972","DOI":"10.1097\/MPH.0000000000002021","article-title":"Care coordination in a SARS-CoV-2-infected child with newly diagnosed medulloblastoma and Fanconi anemia","volume":"43","author":"Field","year":"2021","journal-title":"J Pediatr Hematol Oncol."},{"issue":"10","key":"2024110422225180100_CIT0036","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","article-title":"Treatment of early childhood medulloblastoma by postoperative chemotherapy alone","volume":"352","author":"Rutkowski","year":"2005","journal-title":"N Engl J Med."},{"issue":"1","key":"2024110422225180100_CIT0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pediatrneurol.2015.03.019","article-title":"Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 Phase I\/II Study. A report from the children\u2019s oncology group","volume":"53","author":"Cohen","year":"2015","journal-title":"Pediatr Neurol."},{"issue":"11","key":"2024110422225180100_CIT0038","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.1651-2227.2010.01929.x","article-title":"Fanconi anaemia, BRCA2 and familial considerations - follow up on a previous case report","volume":"99","author":"Bodd","year":"2010","journal-title":"Acta Paediatr."},{"issue":"6","key":"2024110422225180100_CIT0039","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","article-title":"Spectrum and prevalence of genetic predisposition in medulloblastoma: A retrospective genetic study and prospective validation in a clinical trial cohort","volume":"19","author":"Waszak","year":"2018","journal-title":"Lancet Oncol."},{"issue":"4","key":"2024110422225180100_CIT0040","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41591-023-02255-1","article-title":"Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology","volume":"29","author":"Sturm","year":"2023","journal-title":"Nat Med."},{"issue":"12","key":"2024110422225180100_CIT0041","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/neuonc\/noaa241","article-title":"Young children with medulloblastoma: Important open questions and the high-risk dilemma","volume":"22","author":"Mynarek","year":"2020","journal-title":"Neuro Oncol."},{"issue":"23","key":"2024110422225180100_CIT0042","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","article-title":"Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma","volume":"31","author":"Zhukova","year":"2013","journal-title":"J Clin Oncol."},{"issue":"12","key":"2024110422225180100_CIT0043","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/neuonc\/noad114","article-title":"Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome","volume":"25","author":"Kolodziejczak","year":"2023","journal-title":"Neuro Oncol"},{"key":"2024110422225180100_CIT0044","doi-asserted-by":"crossref","first-page":"543531","DOI":"10.4061\/2010\/543531","article-title":"DNA damage induced by alkylating agents and repair pathways","volume":"2010","author":"Kondo","year":"2010","journal-title":"J Nucleic Acids"},{"issue":"12","key":"2024110422225180100_CIT0045","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/neuonc\/noaa102","article-title":"Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on \u201cHead Start\u201d III: A multi-institutional, prospective clinical trial","volume":"22","author":"Dhall","year":"2020","journal-title":"Neuro Oncol"},{"issue":"6","key":"2024110422225180100_CIT0046","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(18)30204-3","article-title":"Risk-adapted therapy for young children with medulloblastoma (SJYC07): Therapeutic and molecular outcomes from a multicentre, phase 2 trial","volume":"19","author":"Robinson","year":"2018","journal-title":"Lancet Oncol."},{"issue":"3","key":"2024110422225180100_CIT0047","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1200\/JCO.19.00845","article-title":"Phase II study of nonmetastatic desmoplastic medulloblastoma in children younger than 4 years of age: A report of the Children\u2019s Oncology Group (ACNS1221)","volume":"38","author":"Lafay-Cousin","year":"2020","journal-title":"J Clin Oncol."},{"issue":"3","key":"2024110422225180100_CIT0048","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0035-1548841","article-title":"Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia","volume":"227","author":"Chao","year":"2015","journal-title":"Klin Padiatr."},{"issue":"2","key":"2024110422225180100_CIT0049","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2014-10-605113","article-title":"HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine","volume":"125","author":"Benajiba","year":"2015","journal-title":"Blood."},{"issue":"12","key":"2024110422225180100_CIT0050","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.bbmt.2007.08.004","article-title":"HLA-matched related donor hematopoietic cell transplantation in 43 patients with Fanconi anemia conditioned with 60 mg\/kg of cyclophosphamide","volume":"13","author":"Bonfim","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"issue":"4","key":"2024110422225180100_CIT0051","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1980.tb07178.x","article-title":"Bone marrow transplantation in Fanconi anaemia","volume":"45","author":"Gluckman","year":"1980","journal-title":"Br J Haematol."},{"issue":"2","key":"2024110422225180100_CIT0052","first-page":"51","article-title":"Medulloblastoma in childhood: Radiation therapy","volume":"100","author":"Jenkin","year":"1969","journal-title":"Can Med Assoc J."},{"issue":"1107","key":"2024110422225180100_CIT0053","doi-asserted-by":"crossref","first-page":"20190601","DOI":"10.1259\/bjr.20190601","article-title":"Paediatric proton therapy","volume":"93","author":"Thomas","year":"2020","journal-title":"Br J Radiol."},{"issue":"24","key":"2024110422225180100_CIT0054","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1200\/JCO.2014.60.1591","article-title":"Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032","volume":"33","author":"Robinson","year":"2015","journal-title":"J Clin Oncol."},{"issue":"22","key":"2024110422225180100_CIT0055","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/1078-0432.CCR-13-1425","article-title":"Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: A pediatric brain tumor consortium study","volume":"19","author":"Gajjar","year":"2013","journal-title":"Clin Cancer Res."},{"issue":"12","key":"2024110422225180100_CIT0056","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJMoa0902903","article-title":"Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449","volume":"361","author":"Rudin","year":"2009","journal-title":"N Engl J Med."},{"issue":"41","key":"2024110422225180100_CIT0057","doi-asserted-by":"crossref","first-page":"69295","DOI":"10.18632\/oncotarget.20619","article-title":"Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor","volume":"8","author":"Robinson","year":"2017","journal-title":"Oncotarget"},{"key":"2024110422225180100_CIT0058","article-title":"Fanconi Anemia. 2002 Feb 14 [Updated 2021 Jun 3]","volume-title":"Gene Reviews \u00ae [Internet].","author":"Mehta","year":"1993\u20132024"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noae111\/58758911\/noae111.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/11\/2125\/60416308\/noae111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/26\/11\/2125\/60416308\/noae111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:23:21Z","timestamp":1730759001000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/26\/11\/2125\/7699169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":58,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,6,26]]},"published-print":{"date-parts":[[2024,11,4]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noae111","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,11]]},"published":{"date-parts":[[2024,6,26]]}}}